Literature DB >> 946508

Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.

M H Jacobs, R M Senior, G Kessler.   

Abstract

Relationships between theophylline dosage, serum theophylline concentration, and theophylline toxicity were evaluated retrospectively in 47 hospitalized adults. The amount of theophylline administered daily varied more than sixfold, from 6 to 38 mg/kg. The serum theophylline concentrations, however, varied 24-fold from 2 to 49 mug/ml. The relationship between daily dosage and serum concentration was unpredictable in an individual patient. Fourteen patients (30%) had a toxic reaction to theophylline. Toxic symptoms, which were not always gastrointestinal, occurred commonly with serum concentrations over 25 mug/ml but were not noted with concentrations below 15 mug/ml. High serum theophylline concentrations and a toxic reaction developed just as often with the oral route as when the drug was given intravenously. In six patients, measurement of serum theophylline concentration disclosed subtherapeutic concentrations. Serum theophylline determination appears to be important clinically in guiding effective and safe usage of theophylline.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 946508     DOI: 10.1001/jama.235.18.1983

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  46 in total

1.  Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophylline.

Authors:  R C Kolbeck; W A Speir; G O Carrier; E D Bransome
Journal:  Lung       Date:  1979       Impact factor: 2.584

2.  Seizures from theophylline use.

Authors:  R G Dellen
Journal:  West J Med       Date:  1983-03

Review 3.  Combined butalbital/acetaminophen/caffeine overdose: case files of the Robert Wood Johnson Medical School Toxicology Service.

Authors:  Christopher Bryczkowski; Ann-Jeannette Geib
Journal:  J Med Toxicol       Date:  2012-12

4.  Biopharmaceutical Evaluation and CMC Aspects of Oral Modified Release Formulations.

Authors:  Rong-Kun Chang; Neil Mathias; Munir A Hussain
Journal:  AAPS J       Date:  2017-07-05       Impact factor: 4.009

5.  Experience of low-dose aminophylline use to relieve minor adverse effects of dipyridamole in patients undergoing stress myocardial perfusion imaging.

Authors:  Li-Fan Lin; Cheng-Yi Cheng; Cheng-Han Hou; Chih-Hung Ku; Neng-Chuan Tseng; Daniel H Y Shen
Journal:  J Nucl Cardiol       Date:  2014-03-14       Impact factor: 5.952

Review 6.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

7.  Intravenous aminophylline in patients already taking oral theophylline: effect on calculated dose of knowledge of serum theophylline concentration on admission.

Authors:  J Wiggins; O A Arbab; D E Stableforth; J G Ayres
Journal:  Thorax       Date:  1986-10       Impact factor: 9.139

Review 8.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

9.  Pharmacokinetics of theophylline in young children with asthma: comparison of rectal enema and suppositories.

Authors:  P Bolme; P O Edlund; M Eriksson; L Paalzow; B Winbladh
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

10.  Impaired theophylline clearance in patients with cor pulmonale.

Authors:  N Vicuna; J L McNay; T M Ludden; H Schwertner
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.